Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,764,225
+$1,073,038 QoQ
Shares Held
351,863
-31.7% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#82
of 626 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026READYSTATE ASSET MANAGEMENT LP holds $5,003,267 across 2 Drug Manufacturers - General names. OGN ranks #1 (95.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OGN |
Organon & Co.
This page
|
351,863 | $4,764,225 | |
| 2 | PFE |
Pfizer Inc
|
9,927 | $239,042 |
All Filings in OGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,764,225 | 351,863 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $3,691,187 | 514,810 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,630,252 | 901,709 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $9,650,621 | 996,965 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $7,431,330 | 499,082 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $8,166,939 | 547,382 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,653,142 | 243,238 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,994,458 | 192,969 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,075,577 | 323,169 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,686,325 | 394,336 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $192,696 | 11,100 | Shares | Sole | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||